Results of External Audit Tender Process
Updated : 11:32
London, 12 November 2018
Georgia Healthcare Group PLC announces results of external audit tender process
Georgia Healthcare Group ("GHG" or "the Group") announces that it proposes that Ernst & Young LLP ("EY") be re-appointed as the Group's auditor. This proposal follows a competitive tender process for the statutory audit contract overseen by the Audit Committee of GHG, resulting in a recommendation which was approved by the Board.
A resolution to approve the re-appointment of EY will be put to shareholders at the Company's AGM in 2019.
The Board would like to thank all firms who participated in the audit tender and looks forward to working with EY again.
Name of authorised official of issuer responsible for making notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 37 hospitals and 16 district polyclinics. GHG is the single largest market participant, accounting for 25% of total hospital bed capacity in the country, as of 30 June 2018. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 27% market share based on net insurance premiums earned and approximately 158,000 insurance customers as at June 2018. GHG employed a total of c.15,500 people as at 30 June 2018, including c.3,600 physicians and 2,900 pharmacists.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze | Irakli Gogia | Ketevan Kalandarishvili |
CEO | CFO | Head of Investor Relations |
+995 322 550505 (5077) | +995 322 550505 (5088) | +995 322 550505 (5079) |
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.